Neuren Pharmaceuticals | NEU - Gewinn Vor Steuern

Aktienkurs
12.58
Täglich Wechseln
-0.42 -3.23%
Monatlich
-1.33%
Jährlich
31.45%
Q2 Prognose
11.77




Gewinn Vor Steuern Veränderung Datum
Akebia Therapeutics USD -11.24M 12.39M 2025-12
Alaunos Therapeutics USD -7.84M 633K 2023-12
Avita Medical AUD -11.64M 12.13M 2025-12
Clinuvel Pharmaceuticals AUD 28.8M 6.9M 2025-06
Dianthus Therapeutics USD -64.43M 27.67M 2025-12
Genetic Signatures AUD -2.45M 2.08M 2025-06
Ionis Pharmaceuticals USD -228M 99M 2025-12
Medical Developments International AUD -149K 466K 2025-06
Neuren Pharmaceuticals AUD 9.86M 161.24M 2025-06
Organon & Co USD 243M 14M 2025-09
PYC Therapeutics AUD -12.57M 13.3M 2025-06
Starpharma Holdings AUD -2.3M 1.94M 2025-06
Tectonic Therapeutic USD -18.97M 63K 2025-12
Telix Pharmaceuticals AUD 76.73M 66.04M 2025-06
Viatris USD -7.9M 209.2M 2025-09
Xeris Pharmaceuticals USD 11.08M 10.46M 2025-12